HDAC6 controls innate immune and autophagy responses to TLR-mediated signalling by the intracellular bacteria Listeria monocytogenes

40Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

Recent evidence on HDAC6 function underlines its role as a key protein in the innate immune response to viral infection. However, whether HDAC6 regulates innate immunity during bacterial infection remains unexplored. To assess the role of HDAC6 in the regulation of defence mechanisms against intracellular bacteria, we used the Listeria monocytogenes (Lm) infection model. Our data show that Hdac6-/-bone marrow-derived dendritic cells (BMDCs) have a higher bacterial load than Hdac6+/+cells, correlating with weaker induction of IFN-related genes, pro-inflammatory cytokines and nitrite production after bacterial infection. Hdac6-/-BMDCs have a weakened phosphorylation of MAPK signalling in response to Lm infection, suggesting altered Toll-like receptor signalling (TLR). Compared with Hdac6+/+counterparts, Hdac6-/-GM-CSF-derived and FLT3L-derived dendritic cells show weaker pro-inflammatory cytokine secretion in response to various TLR agonists. Moreover, HDAC6 associates with the TLR-adaptor molecule Myeloid differentiation primary response gene 88 (MyD88), and the absence of HDAC6 seems to diminish the NF-κB induction after TLR stimuli. Moreover, Hdac6-/-mice display low serum levels of inflammatory cytokine IL-6 and correspondingly an increased survival to a systemic infection with Lm. The impaired bacterial clearance in the absence of HDAC6 appears to be caused by a defect in autophagy. Hence, Hdac6-/-BMDCs accumulate higher levels of the autophagy marker p62 and show defective phagosome-lysosome fusion. These data underline the important function of HDAC6 in dendritic cells not only in bacterial autophagy, but also in the proper activation of TLR signalling. These results thus demonstrate an important regulatory role for HDAC6 in the innate immune response to intracellular bacterial infection.

Figures

  • Fig 1. Deficient intracellular bacteria clearance in Hdac6-/- BMDCs. A) Western blot analysis of HDAC6 in a time-course of infection of BMDCs with Lm. Tubulin was used as a loading control. HDAC6 levels were quantified in five independent experiments. p 0.001, p 0.01 p 0.05. B) CFUs obtained at 0 and 6 hpi from BMDCs infected with L. monocytogenes, S. Typhimurium, E. coli DHDα, and S. aureus at a MOI of 10. Data from 0 hpi are shown as a bacteria entry control. p 0.001, ns>0.05 non-significant; n = 6. C) CFUs of Lm-infected BMDCs obtained at 0, 6, 24 and 32 hpi with a MOI = 10. p 0.001, p 0.05, ns>0.05 non-significant; n = 6. D) CFUs of Lm-infected BMDCs obtained at 0, 2, 4 and 6 hpi with a MOI = 10 and 1. p 0.001, p 0.05, ns>0.05 non-significant; n = 6. E) BMDCs were infected with Lm or Lm-RFP for 6 h and the bacterial signal
  • Fig 2. Deficient intracellular bacteria clearance in Hdac6-/- splenic myeloid populations. A) Quantification of bacterial load in target organs (spleen and liver) at 6 hpi in Hdac6+/+ and Hdac6-/- mice injected with a lethal dose of Lm. Bacterial load is expressed by CFUs per gram of liver (left graph) and per gram of spleen (right graph). p 0.01, n = 6. B) The charts show geometric means of Lm of different splenic populations (monocytes, neutrophils, Tips DCs, total cDCs, cDCs CD8- and cDCs CD8+) gated in the live CD3-CD19-DX5- population of Hdac6+/+ and Hdac6-/- mice injected with a lethal dose of Lm at 6 hpi. p 0.01; n = 6.
  • Fig 3. Impaired bacterial clearance in Hdac6-/- BMDCs is caused by a defect in autophagy. A) Total CFUs in Lminfected BMDCs treated with inhibitors. CFUs were detected at entry (0 hpi) and 6 hpi (bacterial proliferation) using the autophagy inhibitors (3-MA and bafilomycin A1 and the lysosome acidification inhibitors (NH4Cl and cloroquine), ns>0.05 non-significant; n = 6. B) Total CFUs at 0 and 6 hpi in Lm-infected BMDCs treated with the autophagy activator (rapamycin), the NADPH oxidase inhibitor (DPI) and the iNOS inhibitor (1400W). p 0.001; n = 6. C) Total CFUs at 0 and 6 hpi in Lm-infected thioglycollate-elicited macrophages treated with or without bafilomycin A1. p 0.001, ns>0.05 non-significant; n = 6. D) Western-blot analysis of autophagy markers over the time-course of Lm infection in Hdac6+/+ and Hdac6-/- BMDCs. Left panels: Levels were detected of p62, LC3bI and II and HDAC6 in control cells and cells treated
  • Fig 4. Hdac6-/- BMDCs accumulate higher levels of p62. A) Left panels: The charts show geometric means of p62 and Lm gated in the MHCII+CD11c+ population of Hdac6+/+ and Hdac6-/- BMDCs without infection (NI) and at 6 hpi, with and without bafilomycin A1 treatment. The representative histograms on the right show p62 and Lm with and without bafilomycin A1. p 0.001, p 0.01, ns>0.05 non-significant; n = 6. B) Confocal microscopy analysis of p62-Lm colocalization in Lm-infected Hdac6+/+ and Hdac6-/- BMDCs at 6 hpi. Panels show DAPI (blue), Lm (red), p62 (green), and merged views of the three channels, with magnified views of the boxed areas. Yellow indicates p62-Lm co-localization.
  • Fig 5. Defective pro-inflammatory cytokine response to Lm in Hdac6-/- BMDCs. A) PCR analysis of type-I interferons (PanIFN-α and IFN-β), interferon downstream proteins (Mx1, IFIT3 and ISG15), pro-inflammatory cytokines (TNF-α, IL1β and IL-12p40) chemokine receptor (CXCR1) and chemokines (CXCL5 and CXCL10) of Hdac6+/+ and Hdac6-/- BMDCs non-infected (NI) and infected with Lm at 6 hpi (arbitrary units). p 0.001, p 0.01, p 0.05; n = 5–6. B) ELISA analysis of the pro-inflammatory cytokines TNFα, IL1β, IL6 and IL12p70 (pg/ml) and IFN-β in supernatants of Hdac6+/+ and Hdac6-/- BMDCs at 6, 12 and 24 hpi with Lm. p 0.001, p 0.01, p 0.05 ns>0.05 non-significant; n = 5–6.
  • Fig 6. Defective iNOS response to Lm in Hdac6-/- BMDCs. A) Lm-activated iNOS activity. Nitrite levels in supernatants of Lm-infected BMDCs at 6, 12 and 24 hpi. p 0.001; n = 5. B) Western-blot analysis of iNOS induction over the time-course of Lm infection. β-actin was used as a loading control (top panel). The chart shows quantification of iNOS at 4 and 6 hpi. p 0.01, p 0.05; n = 4 (lower panel). C) The panel shows representative histograms of iNOS expressed by Hdac6+/+ and Hdac6-/- BMDCs after exposure to live Lm or HKLM for 24 h (left). The right chart shows the geometric mean of iNOS expression. Non-infected (NI) BMDCs were used as a control of iNOS induction. p 0.01; n = 6.
  • Fig 7. Hdac6-/- BMDCs show defective activation of the Toll-like receptor signalling pathway. A) Western-blot analysis of MAPK activation over the time-course of Lm infection in Hdac6+/+ and Hdac6-/- BMDCs. Total and phosphorylated ERK and AKT were detected. Tubulin was used as a loading control (left). Accompanying charts show quantification of phERK/totalERK and phAKT/totalAKT ratios relative to the loading control, ns nonsignificant; n = 7 (right). B) Western-blot analysis of mTORC1 pathway activation over the time-course of Lm infection in Hdac6+/+ and Hdac6-/BMDCs. Levels of phosphorylated and total p70S6K and S6 were detected. Tubulin was used as a loading control (top panel). Accompanying charts show quantification of php70S6K/total70S6K (n = 5) and phS6/totalS6 (n = 7) ratios relative to the loading control. p 0.01, ns non-significant; (lower panel).
  • Fig 8. Hdac6-/- BMDCs show defective inflammatory cytokine response to Toll-like receptor stimuli. A) ELISA analysis of the pro-inflammatory cytokines TNFα, IL-1β, IL-6 and IL12p70 (pg/ml) in supernatants of Hdac6+/+ and Hdac6-/- BMDCs after treatment for 6, 12 and 24 h with Pam3GSK4. p 0.001, p 0.01, p 0.05, ns>0.05 nonsignificant; n = 5–6. B) ELISA analysis of the pro-inflammatory cytokines TNFα, IL-1β, IL-6 and IL12p70 (pg/ml) in supernatants of Hdac6+/+ and Hdac6-/- BMDCs after treatment for 6, 12 and 24 h with LPS. p 0.001, p 0.01, ns>0.05 non-significant; n = 5–6. C) ELISA analysis of the pro-inflammatory cytokines TNFα, IL-1β, IL-6 and IL12p70

References Powered by Scopus

2490Citations
3453Readers
Get full text
Get full text

Cited by Powered by Scopus

This article is free to access.

Autophagy in intracellular bacterial infection

62Citations
116Readers

This article is free to access.

This article is free to access.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Moreno-Gonzalo, O., Ramírez-Huesca, M., Blas-Rus, N., Cibrián, D., Saíz, M. L., Jorge, I., … Sánchez-Madrid, F. (2017). HDAC6 controls innate immune and autophagy responses to TLR-mediated signalling by the intracellular bacteria Listeria monocytogenes. PLoS Pathogens, 13(12). https://doi.org/10.1371/journal.ppat.1006799

Readers over time

‘18‘19‘20‘21‘22‘23‘240481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 15

68%

Researcher 5

23%

Professor / Associate Prof. 2

9%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 11

42%

Biochemistry, Genetics and Molecular Bi... 7

27%

Immunology and Microbiology 6

23%

Engineering 2

8%

Save time finding and organizing research with Mendeley

Sign up for free
0